Sargent Investment Group, LLC
Position in TMO — Thermo Fisher Scientific Inc.
CIK 1766157
BETHESDA, MD
Position in TMO
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$371,006
-$6,980 QoQ
Shares Held
740
-3.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,924
of 2,606 holders
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Sargent Investment Group, LLC holds $4,035,420 across 3 Diagnostics & Research names. TMO ranks #3 (9.2% of the industry book) .
All Filings in TMO
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $371,006 | 740 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $377,986 | 769 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $437,484 | 755 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $293,553 | 724 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $560,795 | 1,127 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $369,883 | 711 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $410,730 | 664 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $364,980 | 660 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $393,479 | 677 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $462,318 | 871 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $339,133 | 670 | Shares | Sole | 2023-11-13 | |
| No filing history on record for this holder in this stock. | ||||||